APA Zitierstil

Yeleswaram, S., Smith, P., Burn, T., Covington, M., Juvekar, A., Li, Y., . . . Langmuir, P. (2020). Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment. Clinical immunology (Orlando, Fla.), 218, 108517. https://doi.org/10.1016/j.clim.2020.108517

Chicago Zitierstil

Yeleswaram, Swamy, Paul Smith, Timothy Burn, Maryanne Covington, Ashish Juvekar, Yanlong Li, Peg Squier, und Peter Langmuir. "Inhibition of Cytokine Signaling by Ruxolitinib and Implications for COVID-19 Treatment." Clinical Immunology (Orlando, Fla.) 218 (2020): 108517. https://dx.doi.org/10.1016/j.clim.2020.108517.

MLA Zitierstil

Yeleswaram, Swamy, et al. "Inhibition of Cytokine Signaling by Ruxolitinib and Implications for COVID-19 Treatment." Clinical Immunology (Orlando, Fla.), vol. 218, 2020, p. 108517.